Ensayos clínicos

8.676 ensayos encontrados

CompletadoFase 3ClinicalTrials.gov

A Multicenter Study to Evaluate Safety and Tolerability in Patients With Chronic Heart Failure and Reduced Ejection Fraction From PARADIGM-HF Receiving Open Label LCZ696

IntervencionalInicio: 16 de oct de 2014ID: NCT02226120

Aún no reclutaClinicalTrials.gov

Asociación entre hígado graso y esteatosis pancreática en pacientes con síndrome metabólico

ObservacionalInicio: 1 de sept de 2025ID: NCT06757348

CompletadoFase 1ClinicalTrials.gov

Comparative Pharmacokinetic and Pharmacodynamic Study Between 2 Agalsidase Beta Formulations at a Single Dose of 1 mg/kg of Agalsidase (Biosidus) and Fabrazyme (Sanofi Genzyme) as Intravenous Infusion in Male Healthy Volunteers

IntervencionalInicio: 23 de oct de 2021ID: NCT05343715

ReclutandoFase 1ClinicalTrials.gov

Estudio de fase 1b para evaluar la seguridad, tolerabilidad, farmacocinética y eficacia de AMG 193 solo o en combinación con otras terapias en sujetos con tumores torácicos avanzados con deleción homocigota de MTAP (Protocolo Maestro)

IntervencionalInicio: 17 de sept de 2024ID: NCT06333951

CompletadoFase 3ClinicalTrials.gov

A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication

IntervencionalInicio: 31 de jul de 2013ID: NCT01868061

ReclutandoFase 3ClinicalTrials.gov

Un estudio de fase III, multicéntrico, doble ciego, controlado con placebo para evaluar la eficacia y seguridad de la terapia de inducción con RO7790121 en pacientes con enfermedad de Crohn de actividad moderada a grave

IntervencionalInicio: 12 de may de 2025ID: NCT06819891

CompletadoFase 3ClinicalTrials.gov

Adaptive Platform Treatment Trial for Outpatients With COVID-19 (Adapt Out COVID)

IntervencionalInicio: 19 de ago de 2020ID: NCT04518410

CompletadoFase 3ClinicalTrials.gov

Estudio multicéntrico de fase III, abierto, aleatorizado, de imatinib versus nilotinib en pacientes adultos con leucemia mielógena crónica en fase crónica (LMC-FC) cromosoma Filadelfia positivo (Ph+) de reciente diagnóstico.

IntervencionalInicio: 31 de jul de 2007ID: NCT00471497

CompletadoFase 2ClinicalTrials.gov

Ensayo Clínico de Fase 2 con Dosificación Quincenal de Irofulven más Capecitabine en Pacientes con Cáncer de Tiroides Anaplásico o Diferenciado Localmente Avanzado/Metastásico

IntervencionalInicio: 31 de mar de 2005ID: NCT00124527

CompletadoFase 3ClinicalTrials.gov

A Double-Blind, Multi-Center, Multinational, Randomized Withdrawal Study Evaluating the Efficacy and Safety of SR58611A (350mg q12) Versus Placebo in the Prevention of Depression Relapse up to 1 Year in Patients With Major Depressive Disorder Improved After 12 Weeks of Open Treatment With SR58611A (350mg q12)

IntervencionalInicio: 1 de may de 2006ID: NCT00345098

Por invitaciónFase 3ClinicalTrials.gov

Un estudio de extensión abierto para evaluar la seguridad y eficacia de vutrisiran en pacientes con amiloidosis por transtiretina con miocardiopatía (amiloidosis ATTR con miocardiopatía)

IntervencionalInicio: 3 de dic de 2024ID: NCT06679946

CompletadoFase 3ClinicalTrials.gov

A Phase III, Observer-Blind, Randomized, Controlled, Multicenter Study to Evaluate Safety, Tolerability, and Immunogenicity of Two Trivalent Subunit Inactivated Influenza Vaccines in Healthy Children Aged 3 to 8 Years, in Healthy Children/Adolescents Aged 9 to 17 Years,and in Healthy Adults Aged 18 to 64 Years

IntervencionalInicio: 1 de abr de 2007ID: NCT00464672

CompletadoFase 3ClinicalTrials.gov

Liraglutide Effect and Action in Diabetes (LEAD-5): Effect on Glycaemic Control After Once Daily Administration of Liraglutide in Combination With Glimepiride and Metformin Versus Glimepiride and Metformin Combination Therapy, and Versus Insulin Glargine Added to Glimepiride and Metformin Combination Therapy in Subjects With Type 2 Diabetes.A Six-month Randomised, Double-blind, Parallel-group, Multi-centre, Multi-national Trial With an Open-label Treat-to-target Insulin Glargine Control Arm.

IntervencionalInicio: 1 de may de 2006ID: NCT00331851

DesconocidoFase 4ClinicalTrials.gov

Effect of Mosapride on Postoperative Ileus in Patients Undergoing Colorectal Surgery

IntervencionalInicio: 1 de dic de 2015ID: NCT02056405

CompletadoFase 3ClinicalTrials.gov

A Phase III, Randomized, Double-Blind, Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of MK-8228 (Letermovir) Versus Valganciclovir for the Prevention of Human Cytomegalovirus (CMV) Disease in Adult Kidney Transplant Recipients

IntervencionalInicio: 3 de may de 2018ID: NCT03443869

CompletadoFase 3ClinicalTrials.gov

A Multi-centre, Multinational, Open-labelled, Randomised, Parallel-Group Comparison of Insulin Detemir Plus Insulin Aspart With NPH Insulin Plus Human Soluble Insulin in Subjects With Type 1 Diabetes on a Basal-Bolus Regimen

IntervencionalInicio: 1 de mar de 2002ID: NCT01486940

CompletadoFase 3ClinicalTrials.gov

A Phase 3, Randomized, Observer-Blind, Placebo-Controlled, Group-Sequential Study to Determine the Immunogenicity and Safety of a Respiratory Syncytial Virus (RSV) F Nanoparticle Vaccine With Aluminum in Healthy Third-trimester Pregnant Women; and Safety and Efficacy of Maternally Transferred Antibodies in Preventing RSV Disease in Their Infants

IntervencionalInicio: 1 de dic de 2015ID: NCT02624947

ReclutandoFase 3ClinicalTrials.gov

Ensayo de fase 3, multicéntrico, aleatorizado, abierto de trastuzumab deruxtecán en combinación con pembrolizumab frente a quimioterapia basada en platino en combinación con pembrolizumab, como terapia de primera línea en participantes con cáncer de pulmón de células no pequeñas no escamoso localmente avanzado irresecable o metastásico con sobreexpresión de HER2 y TPS de PD-L1 <50% (DESTINY-Lung06)

IntervencionalInicio: 24 de oct de 2025ID: NCT06899126

TerminadoFase 3ClinicalTrials.gov

A Multicenter, Double-Masked, Randomized, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Conbercept Intravitreal Injection in Subjects With Neovascular Age-Related Macular Degeneration (AMD) (PANDA-1)

IntervencionalInicio: 25 de sept de 2018ID: NCT03577899

CompletadoFase 3ClinicalTrials.gov

A Phase 3, Efficacy and Safety Study of Oral Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP)

IntervencionalInicio: 30 de nov de 2017ID: NCT03312634